Tag: Stellest

Myopia myths can shape how families and clinicians understand childhood myopia and myopia progression. Dr. Jennifer Lyerly and Dr. Justin Kwan separate fact from fiction on genetics, screen time, contact lenses, axial length, and treatment expectations—revealing what the evidence means for modern myopia management and myopia control.

Myopia control with Stellest glasses helps slow down nearsightedness in children using an FDA-approved lens technology. Designed for everyday wear, Stellest offers a simple and effective way to protect your child’s vision and reduce the risk of future eye health complications.

EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2.